Lycopodium Limited (ASX:LYL) Insider Peter De Leo Acquires 5,000 Shares

Lycopodium Limited (ASX:LYLGet Free Report) insider Peter De Leo bought 5,000 shares of Lycopodium stock in a transaction on Wednesday, February 19th. The stock was acquired at an average cost of A$10.13 ($6.45) per share, for a total transaction of A$50,670.00 ($32,273.89).

Peter De Leo also recently made the following trade(s):

  • On Monday, December 9th, Peter De Leo bought 19,700 shares of Lycopodium stock. The stock was acquired at an average cost of A$9.96 ($6.34) per share, for a total transaction of A$196,212.00 ($124,975.80).

Lycopodium Price Performance

The firm has a market cap of $455.88 million, a price-to-earnings ratio of 8.91, a price-to-earnings-growth ratio of 2.02 and a beta of 0.43. The company has a quick ratio of 1.58, a current ratio of 2.44 and a debt-to-equity ratio of 9.85.

Lycopodium Cuts Dividend

The firm also recently announced a Interim dividend, which will be paid on Wednesday, April 2nd. Shareholders of record on Wednesday, April 2nd will be issued a $0.10 dividend. This represents a dividend yield of 0.97%. The ex-dividend date of this dividend is Sunday, March 23rd. Lycopodium’s dividend payout ratio is presently 62.50%.

Lycopodium Company Profile

(Get Free Report)

Lycopodium Limited provides engineering and project delivery services in the resources, infrastructure, and industrial processes sectors. It operates through four segments: Mineral, Process Industries, Project Services-Africa, and Others. The company provides engineering and related services to junior exploration companies, multinational producers, and manufacturing and renewable energy facilities; project management, construction management, and commissioning services to the extractive mining industry; and asset management, engineering, architectural, and project delivery services to a range of private and public clients.

Featured Stories

Receive News & Ratings for Lycopodium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lycopodium and related companies with MarketBeat.com's FREE daily email newsletter.